Predictive Models for HTN Screening Developed Using Speech Recordings
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 13, 2024 -- Predictive models for hypertension screening have been developed using speech recordings, with accuracies up to 84 percent for women and 77 percent for men, according to a study published online Sept. 10 in IEEE Access.
Behrad Taghibeyglou, from the University of Toronto, and colleagues proposed a novel framework for detecting hypertension through acoustic analysis of speech. Speech was recorded across multiple sessions, and its temporal and spectral characteristics were analyzed with an aim of identifying indicators of hypertension. Two thresholds were explored for labeling individuals with hypertension: systolic blood pressure (SBP) ≥135 mmHg or diastolic blood pressure (DBP) ≥85 mmHg and SBP ≥140 mmHg or DBP ≥90 mmHg. The study included 245 participants (91 female).
The researchers developed predictive models for each gender; their performance was assessed using leave-one-subject-out validation. For the first threshold, the balanced accuracy achieved was 84 percent for women and 77 percent for men. The corresponding balanced accuracies for the second threshold were 63 percent for women and 86 percent for men.
"These insights pave the way for further development of generalizable, non-invasive, accessible, and cuffless hypertension screening methods utilizing speech analysis," the authors wrote.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-14 06:00
Read more
- Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
- Urban Green Space May Protect Against Heat-Related Health Risks
- FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
- Falling Asleep While Feeding Infants Commonly Reported by Mothers
- 1.5 Million U.S. Adults Have Vision-Affecting Glaucoma
- ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions